Get the free SAVIENT PHARMACEUTICALS INC DEF 14A

This document is a proxy statement for the 2009 Annual Meeting of Stockholders of Savient Pharmaceuticals, Inc. It details the business matters to be considered at the meeting, including the election

How to fill out savient pharmaceuticals inc def

How to fill out SAVIENT PHARMACEUTICALS INC DEF 14A

1. Obtain the latest SAVIENT PHARMACEUTICALS INC DEF 14A document from the SEC's EDGAR database or the company's investor relations website.
2. Review the table of contents to locate the specific sections you need to fill out.
3. Fill in the information about the company's principal executive officers, directors, and executive compensation, making sure to provide accurate and up-to-date details.
4. If applicable, disclose any related party transactions and potential conflicts of interest.
5. Complete the section regarding proposal items such as shareholder voting matters, director elections, and bylaw amendments.
6. Review any materials regarding the company's stock plans and equity awards for completeness.
7. Ensure all shareholder meeting details are included, such as date, time, and location.
8. Review the document for compliance with SEC regulations and company policies.
9. Obtain necessary approvals from the board of directors before finalizing the document.
10. Submit the completed DEF 14A form to the SEC in accordance with filing deadlines.

Who needs SAVIENT PHARMACEUTICALS INC DEF 14A?

1. Shareholders of SAVIENT PHARMACEUTICALS INC who want to understand corporate governance and executive compensation.
2. Regulatory agencies that require compliance with federal securities laws.
3. Potential investors performing due diligence on the company's governance and business strategies.
4. Analysts and researchers studying the pharmaceutical industry and companies' shareholder practices.
5. Legal and compliance teams within the company ensuring adherence to SEC regulations.

For pdfFiller’s FAQs

What is SAVIENT PHARMACEUTICALS INC DEF 14A?

SAVIENT PHARMACEUTICALS INC DEF 14A is a definitive proxy statement filed by Savient Pharmaceuticals, Inc. with the U.S. Securities and Exchange Commission (SEC) to provide shareholders with information about upcoming shareholder meetings and matters to be voted on.

Who is required to file SAVIENT PHARMACEUTICALS INC DEF 14A?

Companies that are publicly traded in the United States, like Savient Pharmaceuticals Inc., are required to file the DEF 14A proxy statement with the SEC when they seek shareholder approval for actions such as electing board members or approving executive compensation.

How to fill out SAVIENT PHARMACEUTICALS INC DEF 14A?

To fill out the DEF 14A, companies must provide detailed information about management, board of directors, executive compensation, shareholder proposals, and any other matters to be presented at the upcoming shareholder meeting, ensuring all information is clear and complies with SEC requirements.

What is the purpose of SAVIENT PHARMACEUTICALS INC DEF 14A?

The purpose of the SAVIENT PHARMACEUTICALS INC DEF 14A is to inform shareholders about important company matters, allowing them to make informed decisions during shareholder meetings, including voting on the election of directors and approval of other corporate actions.

What information must be reported on SAVIENT PHARMACEUTICALS INC DEF 14A?

The DEF 14A must report information such as the background and qualifications of director nominees, details of executive compensation, any proposals by shareholders, and any other significant matters that will be voted on at the shareholder meeting.